Treatment for COVID-19
For non-hospitalized patients with mild to moderate COVID-19 who are at high risk of disease progression, the use of one the following treatments may be recommended.
- Paxlovid, an oral antiviral medication. This is taken orally twice daily for 5 days, started as soon as possible and within 5 days of symptom onset in those aged 12 years and older and weighing at least 88 pounds.
- Remdesivir, an IV antiviral medication. This is administered daily for 3 days, started as soon as possible and within 7 days of symptom onset in those aged 12 years and older and weighing at least 88 pounds. Remdesivir may also be available for some infants.
- Molnupiravir, an oral antiviral medication. This is taken orally twice daily for 5 days, started as soon as possible and within 5 days of symptom onset in those aged 18 years and older when none of the above options can be used. Molnupiravir is not recommended for use in pregnant or breastfeeding patients.
Who can get this treatment?
Treatment is recommended for patients who are at high-risk for disease progression. Examples include:
- Chronic kidney disease
- Diabetes
- Immunosuppressive disease
- Currently receiving immunosuppressive treatment
- Obesity
- Pregnancy
- Aged 65 years and older
- Chronic lung diseases (e.g., COPD, asthma [moderate-to-severe], interstitial lung disease, cystic fibrosis, and pulmonary hypertension)
- Cardiovascular disease or hypertension
- Sickle cell disease
- Neurodevelopmental disorders (e.g., cerebral palsy) or other complex conditions (e.g., genetic or metabolic syndromes and severe congenital abnormalities)
- Having a medical-related technological dependence (e.g, tracheostomy, gastrostomy, or positive pressure ventilation [not related to COVID-19])
Talk to your doctor about treatment options. If you do not have a doctor, please call the Monument Health Nurse Triage Line at 605-755-1350 to find an appointment.
